SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
FAB Pharma, a Biopharma Company Developing Drugs to Treat Severe Bacterial Infections, Raises €2.3 Million in Series A Funding and Begins Recruitment for a Phase I Trial of Its Lead Compound